1 Inoue, K, "Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel." 6 : 2635-2643, 2000
2 Gervaz, P, "Therapeutic potential of the anti-angiogenesis drug TNP-470." 79 : 359-362, 1998
3 Quevillon, S, "The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine." 272 : 1997
4 Park, S. G, "The novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair." 166 : 387-398, 2005
5 O’Reilly, M. S, "The combination of antiangiogenic therapy with other modalities." 8 : 89-99, 2002
6 Hayes, A. J, "Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment." 318 : 853-856, 1999
7 Folkman, J, "Role of angiogenesis in tumor growth and metastasis." 29 : 15-18, 2002
8 Slaton, J. W, "Interferon-a-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule." 5 : 2726-2734, 1999
9 Chang, S. Y, "Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation." 277 : 8388-8394, 2002
10 Folkman, J, "Fundamental concepts of the angiogenic process." 3 : 643-651, 2003
1 Inoue, K, "Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel." 6 : 2635-2643, 2000
2 Gervaz, P, "Therapeutic potential of the anti-angiogenesis drug TNP-470." 79 : 359-362, 1998
3 Quevillon, S, "The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine." 272 : 1997
4 Park, S. G, "The novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair." 166 : 387-398, 2005
5 O’Reilly, M. S, "The combination of antiangiogenic therapy with other modalities." 8 : 89-99, 2002
6 Hayes, A. J, "Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment." 318 : 853-856, 1999
7 Folkman, J, "Role of angiogenesis in tumor growth and metastasis." 29 : 15-18, 2002
8 Slaton, J. W, "Interferon-a-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule." 5 : 2726-2734, 1999
9 Chang, S. Y, "Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation." 277 : 8388-8394, 2002
10 Folkman, J, "Fundamental concepts of the angiogenic process." 3 : 643-651, 2003
11 Kato, T, "Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470) and cytotoxic agents in mice." 54 : 5143-5147, 1994
12 Schwarz, M. A, "Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells." 190 : 341-354, 1999
13 Moser, T. L, "Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin." 98 : 6656-6661, 2001
14 Park, S. G.,, "Dose-dependent biphasic activity of tRNA synthetaseassociating factor, p43, in angiogenesis." 277 : 2002
15 Kao, J, "Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II." 269 : 1994
16 Ye, D, "Augmentation of a humanized anti-HER2 Mab 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor Mab C225." 18 : 731-738, 1999
17 Perrotte, P, "Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice." 5 : 257-265, 1999
18 Moser, T. L, "Angiostatin binds ATP synthase on the surface of human endothelial cells." 96 : 2811-2816, 1999
19 Ko, Y. G, "A cofactor of tRNA synthetase, p43, is secreted to upregulate proinflammatory genes." 276 : 2001